Shingrix approved for Australians 18+ at high risk
14 March, 2022GSK Australia's Shingrix is available on the private market for the prevention of shingles and post-herpetic neuralgia in people aged 18 years and over who are at increased risk of shingles.
Locally developed screening tool detects autism at 11 months
14 March, 2022A new screening tool, developed by researchers from La Trobe University, helps detect autism in very young children.
Mild COVID-19 linked to changes in brain structure: study
09 March, 2022New research reveals the damaging effects of COVID-19 and improves our understanding of how the disease spreads through the central nervous system.
Cell-based influenza vaccine approved for kids 2+
09 March, 2022Cell-based seasonal influenza vaccine Flucelvax Quad has been approved for Australian children aged two years and older.
2022 influenza control: virologist recommends four actions
09 March, 2022With the lifting of border restrictions and quarantine regulations, Australians can anticipate the reintroduction of influenza, according to the authors of an editorial published by the Medical Journal of Australia.
SHPA releases pharmacy standard for heart disease
08 March, 2022The new pharmacy practice standard recommends patient to pharmacist ratios and quality improvement indicators specific to specialist cardiology pharmacists.
Royal Victorian Eye and Ear Hospital implements PSML
07 March, 2022The Royal Victorian Eye and Ear Hospital is said to be the first hospital in Australia to implement the Pharmacist Shared Medicines List medicine safety initiative.
Hepatitis B: new recommendations for clinicians
07 March, 2022New recommendations for the management of hepatitis B have been released in a bid to improve awareness of chronic hepatitis B among clinicians and to increase detection of cases that currently remain undiagnosed.
Missing surgeries will take some time to work through: APHA
04 March, 2022The latest APRA data shows 11,000 anticipated admissions were missing from private hospitals in the last quarter of 2021.
Landmark clinical practice guidelines for children with CMT
04 March, 2022Charcot-Marie-Tooth disease is the most common childhood inherited nerve disorder. Yet until now, there have been no guidelines to help patients manage their condition.
Breast cancer: how often does overdiagnosis occur?
02 March, 2022A new study suggests that overdiagnosis, or the finding of tumours that may never have progressed or caused harm in a woman's lifetime, occurs in about 15% of screen-detected cancers.
COVID-19 antiviral available on the PBS
02 March, 2022Australians at risk of progressing to severe COVID-19 disease will now be eligible to access an oral antiviral treatment through the PBS.
New rare blood disease treatment on PBS
28 February, 2022Ultomiris (ravulizumab) will be listed for the first time for patients with paroxysmal nocturnal haemoglobinuria.
Liver cancer: non-invasive treatment trial to begin soon
25 February, 2022A new non-invasive treatment for inoperable early-stage liver cancer is set to be trialled across Australia this year.
Global trial to investigate fractional COVID-19 boosters
23 February, 2022Up to 3300 healthy adults across Australia, Indonesia and Mongolia will be invited to take part in a global trial investigating the impact of administering reduced COVID-19 booster shots.
